Prana raises US$3.7 million

By Staff writer
Wednesday, 08 December, 2004

A number of US institutional investors have purchased and exercised 9.5 million options in Prana Biotechnology (NASDAQ: PRAN, ASX: PBT) at $0.50 per share, raising US$3.7 million for the company.

The options - originally owned by directors and insiders of Prana - were exercised prior to their scheduled expiry date of December 1, 2004.

The exercise of options increases the total issued shares in Prana to 126,890,821.

Lipid science receives new Australia-led online hub

The Lipid Network launched this month to build links between researchers, clinicians and industry...

Proposed Australian trial eyes up blood testing for Alzheimer's

Utilising networks of GPs across three states, a large-scale study intends on combining digital...

Applications open for $300K pandemic therapeutics fellowships

Applications are now open for the Cumming Global Centre for Pandemic Therapeutics' inaugural...

Content from other channels on our network

Victoria announces "massive" upgrade to one of its busiest hospitals

NSW IRC decision prompts "mixed emotions" from nurses and midwives

Surgical robot expands its scope of procedures

Neuroscientists propose clinical definition for brain fog in menopause

National Pain Alliance launched to advocate for chronic pain

Manufacturing-friendly plastic surface destroys viruses on contact

Queensland Government reports progress on Energy Roadmap after six months

Government fast-tracks funding to support industry and shore up supply chains

AI won’t restart your plant: Why practical skills matter more than ever

POSCO Holdings steps up HILT CRC partnership

Boosting food security ahead of the 2032 Summer Olympics

Antiviral plastic film for surfaces developed at RMIT

Young water professionals take a closer look at food manufacturing

Olives used to predict oil quality before extraction

Scanning providers unite to help accelerate shift to next-gen barcodes